Literature DB >> 32574298

Coronavirus Disease (COVID-19) in the Middle East: A Call for a Unified Response.

Tania Sawaya1, Tala Ballouz2, Hassan Zaraket3, Nesrine Rizk4.   

Abstract

Entities:  

Keywords:  Arab league; COVID-19; Middle East; SARS-CoV-2; coronavirus disease; pandemic preparedness and response

Mesh:

Year:  2020        PMID: 32574298      PMCID: PMC7248320          DOI: 10.3389/fpubh.2020.00209

Source DB:  PubMed          Journal:  Front Public Health        ISSN: 2296-2565


× No keyword cloud information.
The Middle East—traditionally considered to be composed of the Arab-speaking countries in the Eastern Mediterranean region in addition to Iran—has continuously been considered a hotspot for infectious diseases (1). In addition to cross-border travel, its countries attract millions of international travelers each year for tourism, business, and pilgrimage. Furthermore, it remains an area of political turmoil and economic instability. Middle Eastern nations vary greatly in resources, growth indices, and economic strengths (2). For that, budget gaps (3) and difficulty in securing essential resources could compromise the response to an infectious disease outbreak. Violent conflicts have weakened the health infrastructure of several countries in the region and displaced millions of people. The densely populated refugee camps are particularly worrying. Poor hygiene measures and fragmented access to healthcare (4) have rendered these populations more vulnerable to disease and left out of pandemic preparedness (5, 6). It is also worth noting that Middle Eastern populations have high rates of diabetes (7) and cardiovascular problems (8) that have been found to be risk factors for severe COVID-19 disease (9). For all of those reasons, the spread of COVID-19 in the region is particularly alarming and invites serious dialogue, transparency, and cooperation. In March 2020, the WHO declared the novel coronavirus outbreak a pandemic. It has since triggered a global lockdown and disrupted international travel, causing an unprecedented economic crisis (10). The Middle East witnessed a rapid rise in the number of confirmed cases with Iran emerging as its epicenter. This outbreak comes as yet another striking reminder that the preparedness of Middle Eastern countries' healthcare systems for emerging global infectious diseases is still lagging (11). In addition, there have been no clear strategies or plans shared by countries in the region to suggest a coordinated response. The Arab League as an entity has not addressed this issue and pre-scheduled meetings were postponed due to the evolving COVID-19 situation. This appears as a missed opportunity for collaboration and cooperation between countries that share a lot more than borders. Although there has not been a sign of a coordinated region-wide response yet, affected countries in the Middle East are trying to contain the outbreak individually. The response of those countries was variable and largely dictated by the mounting fear and rapid expansion of the COVID-19 outbreak worldwide (12). The rapid surge of COVID-19 in Iran was overwhelming and contributed to fueling the epidemic in nine neighboring countries and Canada (13, 14). Although initially criticized for underreporting cases, Iran's cooperation with the WHO's Regional Office for the Eastern Mediterranean (EMRO) seems to have been productive in making the reports more timely (15). The country's capacity to deal with this pandemic, though, like many others' in the region, is limited (16). More recently, Egypt faced a rapid surge in the number of infections and deaths as public health measures were late to be introduced (17, 18). At the time of writing this piece, several countries are still reporting an increase in the number of cases, probably reflecting increased testing capacity (3, 19). In fact, many of the Gulf Cooperation Council's (GCC) countries have taken notable measures to increase testing and rank among the highest countries in the world in terms of tests per million inhabitants (20). However, concerns are high regarding a potential outbreak among migrant workers, most of whom live in substandard, and crowded conditions (12). The WHO-EMRO developed a regional strategic preparedness and response plan to aid Middle Eastern countries in building capacity to respond to the COVID-19 pandemic at an attempt to build a coordinated response (3). Decisions to close borders and restrict travel from affected nations were taken by many countries in the region, albeit considered delayed by some (21). At this point, most countries are under lockdown and are only admitting flights in the case of repatriation, cargo, or humanitarian aid. Some nations have also banned the exportation of medical supplies to ensure local demand is met (3). Countries such as Lebanon and the UAE took early measures to contain the outbreak, enforcing school closures, and other forms of social distancing. Authorities in Saudi Arabia canceled Umrah pilgrimage and access to Mecca to non-residents in an effort to contain the rapidly-spreading virus (22). Now with the start of Ramadan, the regional, and local agencies are also promoting safe practices (3). Governments and the WHO have resorted to TV and social media outlets and even mobile operators (23) to spread awareness and promote physical distancing while fighting the “infodemic” throughout the Middle East. It is worth noting that the region had already witnessed outbreaks of the two other novel coronaviruses, SARS-CoV and MERS-CoV, as well as the 2009 H1N1 pandemic. Affected countries had consequently learned some lessons in terms of handling outbreaks (24, 25). For example, shortly after the discovery of MERS-CoV, the Saudi ministry of health established the Command and Control System and the Saudi Center for Disease Control and Prevention. Today, they lead the country's frontline response to SARS-CoV-2. Other countries like Qatar put together emergency preparedness plans that have effectively reduced the number of MERS-CoV cases (26) over the last 8 years. Most of the countries in the region also established national influenza centers following the 2009 H1N1 pandemic, many of which were supported by the WHO's Pandemic Influenza Preparedness Framework (PIPF). More recently, Dubai has emerged as the transportation hub for WHO relief efforts, handling over 88% of worldwide aide shipments. Kuwait also topped the WHO COVID-19 relief fund donors list with over 40 million USD (3). Thus, the Middle East possesses different levels of expertise, frontline experience, logistical skills, and financial resources that, if shared, could be greatly beneficial for its populations and ramp up the effectiveness of its countries' prevention and response plans. So why has that cooperation not happened yet? And how different would the situation be if countries had worked together from the start? The political divides are probably the main obstacle to more collaboration among Middle Eastern countries as tensions and polarization weigh on diplomatic relationships. The Gulf Cooperation Council—comprising the UAE, KSA, Oman, Kuwait, Qatar, and Bahrain—has emerged as best prepared to respond to this pandemic as argued for above, while countries like Yemen (27), Libya and Syria, and territories like the Gaza strip (28, 29) are nowhere near that capacity. Local protests were also undergoing in Iraq and Lebanon when confinement orders to curb the spread of the virus were issued. The variation in the number of cases between countries may also reflect the discrepancies in preparedness and response. For example, while Saudi Arabia has had more than 25,000 cases so far, Syria has reported only 44 cases. Similarly, the case fatality rate (CFR) is highly variable around the region, ranging from 0.2% in Djibouti to 7.0% in Sudan and Syria (excluding Yemen because of statistical unreliability) (19). It is also worth noting that, of all confirmed cases reported to the WHO-EMRO, only 3.4% have been documented in detail (3). This could seriously impede research in the region and discourage cooperation. The region as a whole should help secure a budget to fund prevention and response efforts for internally displaced people, refugees, and migrant workers. In addition, a collective investment in telehealth or other methods to ensure care for chronic conditions for the length pandemic could be the base for a fruitful collaboration (30). Finally, detailed COVID-19 case report submissions to the WHO should drastically increase. This would secure a solid database for regional and local experts' research endeavors that will consequently inform policy and accurately document the epidemiology of COVID-19 in the Middle East. As most countries are studying strategies to re-open businesses and borders, regional cooperation may provide the necessary exchange of expertise, and resources to halt the virus' spread, and allow for a safe resumption of human activity. With no vaccine or approved treatment on the horizon, the COVID-19 pandemic is expected to linger, forcing countries everywhere to adapt to the new normal. Although it may be too late to build a unified response for all of the Middle East it might not be too late to show some coordination—especially for richer states to provide logistical, technical, and financial assistance to their neighbors. Public health initiatives might be more effective if coordinated within subregions of the MENA namely the Maghreb (North Africa), Mashreq (Levant), and Gulf since they have more similar healthcare systems and demographics (31). The role of the WHO EMRO has been instrumental in bridging gaps and regional readiness. Aggressive containment efforts and significant public engagement should be urgently mobilized in the hopes of disrupting the spread of COVID-19 in the Middle East. No country is isolated from the other, so cooperation and coordination would only be beneficial in preventing a possible public health catastrophe. If we won't unite now, then when?

Author Contributions

NR conceived the presented idea. NR and TS wrote the manuscript with contribution from TB and HZ. All authors commented on and contributed to the shaping of the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  15 in total

Review 1.  Diabetes epidemic sweeping the Arab world.

Authors:  Bisher Abuyassin; Ismail Laher
Journal:  World J Diabetes       Date:  2016-04-25

2.  The "Arab World" is Not a Useful Concept When Addressing Challenges to Public Health, Public Health Education, and Research in the Middle East.

Authors:  Iain Blair; Michal Grivna; Amer Ahmad Sharif
Journal:  Front Public Health       Date:  2014-04-09

Review 3.  Emerging and Reemerging Diseases in the World Health Organization (WHO) Eastern Mediterranean Region-Progress, Challenges, and WHO Initiatives.

Authors:  Evans Buliva; Mohamed Elhakim; Nhu Nguyen Tran Minh; Amgad Elkholy; Peter Mala; Abdinasir Abubakar; Sk Md Mamunur Rahman Malik
Journal:  Front Public Health       Date:  2017-10-19

4.  Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.

Authors:  Mandeep R Mehra; Sapan S Desai; SreyRam Kuy; Timothy D Henry; Amit N Patel
Journal:  N Engl J Med       Date:  2020-05-01       Impact factor: 91.245

5.  Cardiovascular risk factor burden in Africa and the Middle East across country income categories: a post hoc analysis of the cross-sectional Africa Middle East Cardiovascular Epidemiological (ACE) study.

Authors:  Frederick J Raal; Alawi A Alsheikh-Ali; Mohamed I Omar; Wafa Rashed; Omar Hamoui; Abdoul Kane; Mohamed Alami; Paula Abreu; Walid M Mashhoud
Journal:  Arch Public Health       Date:  2018-02-12

6.  COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia.

Authors:  Shahul H Ebrahim; Ziad A Memish
Journal:  Lancet       Date:  2020-02-27       Impact factor: 79.321

7.  COVID-19 battle during the toughest sanctions against Iran.

Authors:  Amirhossein Takian; Azam Raoofi; Sara Kazempour-Ardebili
Journal:  Lancet       Date:  2020-03-18       Impact factor: 79.321

Review 8.  The socio-economic implications of the coronavirus pandemic (COVID-19): A review.

Authors:  Maria Nicola; Zaid Alsafi; Catrin Sohrabi; Ahmed Kerwan; Ahmed Al-Jabir; Christos Iosifidis; Maliha Agha; Riaz Agha
Journal:  Int J Surg       Date:  2020-04-17       Impact factor: 6.071

9.  Telemedicine in the Era of COVID-19.

Authors:  Jay Portnoy; Morgan Waller; Tania Elliott
Journal:  J Allergy Clin Immunol Pract       Date:  2020-03-24

10.  Hepatitis A Virus Genotype IB Outbreak among Internally Displaced Persons, Syria.

Authors:  Malak Kaddoura; Rasmieh Allaham; Abdinasir Abubakar; Amani Ezzeddine; Amal Barakat; Peter Mala; Hassan Zaraket
Journal:  Emerg Infect Dis       Date:  2020-02-17       Impact factor: 6.883

View more
  11 in total

Review 1.  An exploration of the political, social, economic and cultural factors affecting how different global regions initially reacted to the COVID-19 pandemic.

Authors:  Julian W Tang; Miguela A Caniza; Mike Dinn; Dominic E Dwyer; Jean-Michel Heraud; Lance C Jennings; Jen Kok; Kin On Kwok; Yuguo Li; Tze Ping Loh; Linsey C Marr; Eva Megumi Nara; Nelun Perera; Reiko Saito; Carlos Santillan-Salas; Sheena Sullivan; Matt Warner; Aripuanã Watanabe; Sabeen Khurshid Zaidi
Journal:  Interface Focus       Date:  2022-02-11       Impact factor: 3.906

2.  Jordan's Pandemic Influenza Preparedness (PIP): A Reflection on COVID-19 Response.

Authors:  Khalid A Kheirallah; Mohammed Al-Nusair; Shahed Aljabeiti; Nadir Sheikali; Abdallah Alzoubi; Jomana W Alsulaiman; Abdel-Hameed Al-Mistarehi; Hamed Alzoubi; Ayman Ahmad Bani Mousa; Mohammed Z Allouh
Journal:  Int J Environ Res Public Health       Date:  2022-06-12       Impact factor: 4.614

3.  Pancreatic cancer in the MENA region, a bibliometric review.

Authors:  Hasan Nassereldine; Hussein Awada; Adel Hajj Ali; Mohammad Zeineddine; Zahy Abdul Sater; Yasser Shaib
Journal:  Ecancermedicalscience       Date:  2022-04-29

4.  Tracking COVID-19 urban activity changes in the Middle East from nighttime lights.

Authors:  Eleanor C Stokes; Miguel O Román
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

5.  Prostate cancer in the Arab world: Bibliometric review and research priority recommendations.

Authors:  Adel Hajj Ali; Hussein Awada; Hasan Nassereldine; Mohammad Zeineddine; Zahy Abdul Sater; Albert El-Hajj; Deborah Mukherji
Journal:  Arab J Urol       Date:  2022-01-23

6.  What is the preparedness and capacity of palliative care services in Middle-Eastern and North African countries to respond to COVID-19? A rapid survey.

Authors:  Sabah Boufkhed; Richard Harding; Tezer Kutluk; Abdullatif Husseini; Nasim Pourghazian; Omar Shamieh
Journal:  J Pain Symptom Manage       Date:  2020-11-20       Impact factor: 3.612

7.  Is BCG associated with reduced incidence of COVID-19? A meta-regression of global data from 160 countries.

Authors:  Melvin Joy; B Malavika; Edwin Sam Asirvatham; Thambu David Sudarsanam; L Jeyaseelan
Journal:  Clin Epidemiol Glob Health       Date:  2020-09-05

8.  Temporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa.

Authors:  Malik Sallam; Nidaa A Ababneh; Deema Dababseh; Faris G Bakri; Azmi Mahafzah
Journal:  Heliyon       Date:  2021-01-20

9.  Demand for mitigating the risk of COVID-19 infection in public transport: The role of social trust and fatalistic beliefs.

Authors:  Mohsen Fallah Zavareh; Milad Mehdizadeh; Trond Nordfjærn
Journal:  Transp Res Part F Traffic Psychol Behav       Date:  2021-12-23

10.  Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia.

Authors:  Donal Bisanzio; Richard Reithinger; Ada Alqunaibet; Sami Almudarra; Reem F Alsukait; Di Dong; Yi Zhang; Sameh El-Saharty; Christopher H Herbst
Journal:  BMC Med       Date:  2022-02-07       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.